JW Pharmaceutical Corporation (KRX:001060)
South Korea · Delayed Price · Currency is KRW 28,700
+350 (1.23%)
At close: May 21, 2026
JW Pharmaceutical Company Description
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally.
It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others.
The company was founded in 1945 and is headquartered in Seoul, South Korea.
JW Pharmaceutical Corporation
| Country | South Korea |
| Founded | 1945 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
Contact Details
Address: JW Gwacheon Tower, 38 Gwacheon-si South Korea | |
| Phone | 82 2 8406 777 |
Stock Details
| Ticker Symbol | 001060 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7001060003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sung-Yeol Lee | Chief Executive Officer, Head of Product Development and Management and Director |
| Young-Sub Shin | Chief Executive Officer, Head of Sales and Marketing and Inside Director |
| Jae-Kwang Jeon | Head Managing Director and Head of Public Relation |
| Hyun-seok Han | Head of Product Plant |
| Kim Yong Kwan | Development Head and Internal Director |